Solid-State Innovation

Ilika Plc

The global transition towards electrification and sustainable energy solutions has placed solid-state battery (SSB) technology at the forefront of innovation. SSBs offer significant advantages over traditional lithium-ion batteries, including enhanced safety, higher energy density, and longer lifespan. These benefits are particularly crucial for applications in electric vehicles (EVs), medical devices, and industrial Internet of Things (IoT) systems.

In the EV sector, the demand for batteries that can provide longer range, faster charging, and improved safety is intensifying. SSBs address these needs by eliminating flammable liquid electrolytes, thereby reducing the risk of fires and enabling more compact battery designs. This advancement is essential for the broader adoption of EVs, as consumers seek vehicles that are both efficient and safe.

Similarly, in the medical field, the miniaturisation of devices such as pacemakers and neurostimulators necessitates power sources that are both small and reliable. SSBs meet this requirement by offering high energy density in a compact form factor, ensuring that medical implants can operate effectively over extended periods without frequent replacements.

Industrial IoT applications also benefit from SSB technology. Sensors deployed in remote or harsh environments require batteries that can withstand extreme conditions and provide long-term power without maintenance. SSBs, with their robust construction and longevity, are well-suited to meet these demands, facilitating the growth of smart infrastructure and automation.

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika’s Stereax batteries set for Medical Technology Ireland showcase

Ilika’s Stereax batteries will be showcased by Cirtec Medical at Medical Technology Ireland, giving the company targeted exposure in the medical device market.

Ilika CEO Graeme Purdy discusses Stereax revenues and Goliath opportunities

Ilika CEO Graeme Purdy discusses first Stereax revenues, grant support for Goliath, EV market trends, and opportunities in defence and e-bikes.

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately £1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Search